FDBusiness.com

Nestle Health Science Develops Brain Health Portfolio With New Acquisition

 Breaking News
  • EU Agri-food Exports are Holding Strong The value of EU agri-food exports reached €137.9 billion in 2017, corresponding to a sustained increase by 5.1% in value terms compared to 2016. Published by the European Commission, the latest monthly trade report details the export values for different sectors and origin. Major gains in annual values have been achieved in agri-food exports to the USA [...]...
  • Danone Continues to Make Solid Progress With Strong 2017 Results Danone has posted consolidated sales of €24.68 billion for 2017, up by 2.5% on a ‘like-for-like New Danone’ basis (reflecting the integration of the WhiteWave acquisition), including a 3.9% rise in value showing continued mix and value enhancement in all business sectors, which offset a 1.4% decline in volume. Full-year reported sales were up 12.5% [...]...
  • Nestlé Reports Weak Sales But Margins Improve Nestlé has reported a 0.4% increase in sales to SFr89.8 billion (€77.7 billion) for 2017. Net divestments reduced sales by 1.9%, largely related to the creation of the Froneri ice cream joint venture. Foreign exchange had a minimal negative impact of 0.1%. Organic growth was 2.4%, with 1.6% of real internal growth (RIG) and pricing [...]...
  • Customized Ingredient Solutions are the Way to More and Better Gluten-free Bakery DuPont Nutrition & Health has announced the results of a consumer survey where consumers in four key European markets were asked about their attitudes to gluten-free bakery products. The survey results have revealed untapped potential for bakers to develop more and better-quality products with extra nutritional benefits. While only an estimated 1 percent of the population [...]...
  • Leading Retailers Join the UK’s Big Plastics Debate Coca Cola, Co-Op, Asda, Marks & Spencer and Iceland will come together under one roof for the first time at Packaging Innovations 2018, to talk about the UK’s hottest topic – plastics in packaging. These leading brands will form a panel, as part of the show’s Big Plastics Debate, discussing the road ahead for packaging [...]...

Nestle Health Science Develops Brain Health Portfolio With New Acquisition

Nestle Health Science Develops Brain Health Portfolio With New Acquisition
July 20
11:23 2012

Nestle Health Science has acquired a stake in a US firm Accera, to support the ongoing trials and rollout of the firm’s key brand, Axona, a medical food intended for the clinical dietary management of mild to moderate Alzheimer’s disease, already on the market in the US. Axona fits the company’s ambition to develop a strong portfolio of nutrition-based solutions to manage and prevent disease.

Accera is a privately-held US-based company which specialises in the research, development and commercialisation of medical foods for neurodegenerative disorders like Alzheimer’s which affects more than 30 million people worldwide. The terms of the transaction are not being disclosed.

“Our stake in Accera is a strategic step forward in building up our brain health portfolio,” says Nestle Health Science president and chief executive Luis Cantarell. “Axona is an innovative medical food with a well understood mode of action and offers the potential for personalised nutrition for AD patients.”

Alzheimer’s disease (AD) is the most common adult form of dementia and results in chronic and irreversible cognitive impairment. As AD progresses, the brain becomes less able to use glucose for the energy it needs.

Accera’s ongoing clinical trials show that Axona is metabolised by the liver to produce ketone bodies, which are naturally occurring compounds the brain can use as an alternative energy source. This results in improved memory and cognitive function in mild to moderate AD patients. Axona is already on the market in the US, prescribed to up to 30,000 people with mild to moderate Alzheimer’s.

Nestle has many years of experience researching the relationship between nutrition and cognitive function.

Nestle Health Science, a fully owned subsidiary of Nestle, aims to pioneer a new industry between the traditional nutrition and pharmaceutical industries through the development of science-based personalised nutritional solutions and shaping a new approach to disease prevention and management.

Building on its core HealthCare Nutrition business, Nestle Health Science has ambitions to address chronic conditions in the area of Gastrointestinal Health, Metabolic Health and Brain Health.

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • February 25, 2018fish international
  • February 27, 2018Warsaw Gastro Show
  • February 27, 2018Int'l Food Fair
  • February 28, 2018GAST
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements